ADC Therapeutics SA Pre-Tax Profit Margin 2019-2023 | ADCT
ADC Therapeutics SA pre-tax profit margin from 2019 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| ADC Therapeutics SA Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2023-03-31 |
$0.18B |
$-0.20B |
-107.69% |
| 2022-12-31 |
$0.21B |
$-0.15B |
-73.68% |
| 2022-09-30 |
$0.16B |
$-0.19B |
-121.79% |
| 2022-06-30 |
$0.09B |
$-0.21B |
-225.81% |
| 2022-03-31 |
$0.08B |
$-0.22B |
-271.25% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.192B |
$0.210B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
